November 27, 2024

Ravulizumab and Efgartigimod in Myasthenia Gravis – Neurology® Journals

November 20, 2024

Understanding Patient Perspectives Around Myasthenia Gravis Treatment May Help Optimize Care – AJMC

November 15, 2024

Elevated C1s/C1-INH in serum and plasma of myasthenia gravis patients – ScienceDirect.com

November 14, 2024

Eculizumab Versus Rituximab for Refractory Antiacetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: A Single-Center Experience – Wiley Online Library

November 13, 2024

Genome-wide meta-analysis of myasthenia gravis uncovers new loci and provides insights into polygenic prediction – Nature